Features
Getting to the Heart of the Matter: A Review of Potential Drug Interactions With Cardiac Medications
Cardiac drug interactions make up almost 25% of all preventable adverse drug reactions.
Your search for Warfarin returned 6 results
Features
Direct-to-Consumer Genomic Testing: A Regulatory Debate
The FDA decision that 23andMe's Saliva Collection Kit and Personal Genome Service (PGS) should be classified as a medical device was highly controversial. Two experts weigh in on this complex issue.
Features, News
Consider CBD-Drug Interaction Potential: An Expert Interview
To shed light on this complex subject, MPR interviewed Joshua D Brown, PharmD, PhD, Assistant Professor, Pharmaceutical Outcomes & Policy.
Features
Pharmacogenetics: Where Is It Headed?
When the Human Genome Project was completed in 2001, it was anticipated that by 2020 the pharmacogenomics approach for predicting drug responsiveness would become standard practice.
Features
Pharmacotherapies for Familial Hypercholesterolemia
Familial hypercholesterolemia (FH), an inherited genetic disorder characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) levels, affects an estimated 620,000 Americans and is generally underdiagnosed and undertreated.
Features
Evidence-Based Dietary Guidance for IBD Patients
The incidence of inflammatory bowel disease has been rising, although the reasons for this increase are unclear. Several environmental factors may be responsible, although smoking is the only established environmental risk factor.
